The program's goal is to ultimately help improve appropriate patient access, safety, and quality of care while helping government programs contain exploding costs for new pharmaceutical therapies.
The aim of the program is to enhance patient accessibility, safety, and medical excellence while helping government initiatives manage soaring expenses for innovative medications.